Performing interventional cardiology procedures through the radial artery in the patient’s wrist, rather than the femoral artery in the groin, can improve patient outcomes, according to Mauricio G. Cohen, M.D., professor of medicine and director of the Cardiac Catheterization Laboratory at the University of Miami Miller School of Medicine.
UHealth's new Hypertension Clinic provides in-depth screening and personalized treatment for high blood pressure, the number one risk for heart attack and stroke, the leading causes of death in the United States. “About 45 percent of U.S. adults have high blood pressure, but many don’t realize it until they show up in the emergency room,” said Maria Carolina Delgado-Lelievre, M.D., assistant professor of medicine.
A Puerto Rican patient with X-linked retinitis pigmentosa (XLRP) is hoping to save his vision after an innovative gene therapy procedure at Bascom Palmer Eye Institute at the University of Miami Miller School of Medicine. On August 23, Julio Adorno Nieves, 23, became the first U.S. patient to receive new genes for his inherited, blinding condition in a worldwide Nightstar Therapeutics clinical trial.
In honor of his landmark research identifying the genes that cause deafness and its translation to patient care, Xue Zhong Liu, M.D., Ph.D., was recently honored with the Marian and Walter Hotchkiss Chair in Otolaryngology. Dr. Liu — an internationally renowned researcher, author, educator, and otolaryngologist — received the chair August 30 during a ceremony at the Lois Pope LIFE Center.
The Florida Cancer Data System, the State of Florida’s legislatively mandated population-based registry located at Sylvester Comprehensive Cancer Center, has received three important distinctions for the quality of its cancer registry data. For the 16th consecutive year, the Florida Cancer Data System (FCDS) has received Gold Certification from the North American Association of Central Cancer Registries.
A cross-departmental team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has received a five-year, $2 million grant from the National Cancer Institute to study ways to protect kidneys from radiation therapy. Specifically, the investigators will be seeking new information about the molecular mechanisms of radiation nephropathy.
Lindsey Finch, a fourth-year student at the University of Miami Miller School of Medicine, has received the Chair’s Recognition Award from the Florida Board of Medicine. The award recognizes third- and fourth-year students at Florida medical schools who “exemplify the professionalism, moral character, compassion and intellect essential to a future leader of the medical profession.”
UHealth Tower, a unit of University of Miami Hospital and Clinics, has received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke Gold Plus Quality Achievement Award. The award recognizes the hospital’s commitment to ensuring that stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence.
The Florida Chapter of the American Academy of Pediatrics awarded Jeffrey P. Brosco, M.D. Ph.D., professor of clinical pediatrics and associate director of the Mailman Center for Child Development at the University of Miami Miller School of Medicine, with the 2018 Audrey Lincourt Schiebler, FAAP, and Gerold Schiebler, M.D., FAAP 2018 Advocacy Award.
Physician-researchers with the University of Miami Health System and the Miller School Medicine recently enrolled the first patient in a phase III trial of the drug Arimoclomol for the treatment of amyotrophic lateral sclerosis. The randomized patient received the drug on August 10. ALS, also known as Lou Gehrig’s disease, is a rapidly progressive, fatal disease that attacks the nerve cells that control voluntary muscles.